Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

45.66
-0.1877-0.41%
Volume:1.41M
Turnover:64.25M
Market Cap:109.41B
PE:24.49
High:45.74
Open:45.49
Low:45.32
Close:45.85
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:0.62
T/O Rate:0.07%
Dividend:2.40
Dividend Rate:5.26%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.36
PE(LYR):12.15

Loading ...

Sanofi’s SAR445399 Lung Trial Moves Ahead: What Investors Should Watch

TIPRANKS
·
May 15

Google AI legend raises big money for startup targeting this cutting-edge goal

Dow Jones
·
May 13

Global Pharmaceutical Giants Report Robust Earnings, Increasing Investments in China

Deep News
·
May 07

Sanofi Needs Acquisitions to Overcome Pipeline Disappointments -- Market Talk

Dow Jones
·
May 07

Regeneron, Sanofi present results from Dupixent Phase 4 trial

TIPRANKS
·
May 05

Sanofi appoints Belén Garijo CEO, effective May 1, 2026

Reuters
·
May 05

Sanofi invests C$294M to expand AI Center of Excellence in Toronto

TIPRANKS
·
May 05

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
May 04

Regeneron Flags FDA Delays For Eylea HD Prefilled Syringe

Benzinga Earnings
·
Apr 30

Sanofi appoints Belén Garijo CEO, effective May 1

Reuters
·
Apr 30

Regeneron Earnings Beat Expectations. Upcoming Cancer Data Matter More for the Stock. -- Barrons.com

Dow Jones
·
Apr 29

Sanofi's New CEO Needs to Be Clear on Strategy -- Market Talk

Dow Jones
·
Apr 27

Sector Update: Health Care

MT Newswires Live
·
Apr 25

Sanofi Prices $2.7 Billion in Bonds in Three-Part Offering

MT Newswires Live
·
Apr 25

Sanofi Says Secondary Progressive Multiple Sclerosis Treatment Recommended for Approval in EU

MT Newswires Live
·
Apr 24

European Equities Traded in US as ADRs Ease in Thursday Trading

MT Newswires Live
·
Apr 23

Sector Update: Health Care Stocks Decline Premarket Thursday

MT Newswires Live
·
Apr 23

Sanofi SA reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 23

Analysts Conflicted on These Healthcare Names: Sanofi (SNY), BrightSpring Health Services, Inc. (BTSG) and Collegium Pharmaceutical (COLL)

TIPRANKS
·
Apr 23

Sanofi's Dupixent Success Masks R&D Concerns as New CEO Takes the Helm

Stock News
·
Apr 23